Johnson & Johnson (NYSE:JNJ) has raised its offer to settle thousands of lawsuits alleging its baby powder caused cancer to over $8.2B, people familiar with the matter told Bloomberg, compared to ...

Johnson & Johnson has boosted to more than $8.2 billion its offer to settle thousands of lawsuits by people who say its baby powder gave them cancer, according to people familiar with the matter.

J&J's $8.2 Billion Settlement Linked To Iconic Baby Powder Faces Court Test After months of wrangling, a federal judge in Houston early next year will decide whether J&J's bid to quickly settle ...

J&J has won most of the trials in ovarian cancer cases and it successfully appealed some of its initial losses, with a $2 billion verdict standing as an outlier loss for the company.

Television advertisements soliciting claims from people who say they got cancer from talc powder products dramatically increased in September, the same month that Johnson & Johnson said it would ...

Johnson & Johnson is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal actions alleging its Baby Powder and other talc products ...

J&J announced in May that it had resolved 95% of claims alleging that asbestos contamination in its baby powder led to mesothelioma, a type of cancer affecting tissues around the heart and lungs.

J&J faces lawsuits from more than 62,000 plaintiffs alleging that its baby powder and other talc products were contaminated with asbestos and caused ovarian and other cancers.

J&J’s decision to sweeten its settlement offer would bring the total the firm has agreed to pay out – or already expended – to resolve baby powder cases to more than $13.4 billion.